Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.

@article{Collet2014HypoxiaregulatedOO,
  title={Hypoxia-regulated overexpression of soluble VEGFR2 controls angiogenesis and inhibits tumor growth.},
  author={Guillaume Collet and Nathalie Lamerant-Fayel and Magdalena Tertil and Bouchra El Hafny-Rahbi and Jacek Stepniewski and Alan Guichard and Alexandra Foucault-Collet and Krzysztof Klimkiewicz and St{\'e}phane P{\`e}toud and Agata Matejuk and Catherine Grillon and Alicja J{\'o}zkowicz and Jozef Dulak and Claudine Kieda},
  journal={Molecular cancer therapeutics},
  year={2014},
  volume={13 1},
  pages={165-78}
}
VEGFs are found at high levels in hypoxic tumors. As major components directing pathologic neovascularization, they regulate stromal reactions. Consequently, novel strategies targeting and inhibiting VEGF overproduction upon hypoxia offer considerable potential for modern anticancer therapies controlling rather than destroying tumor angiogenesis. Here, we report the design of a vector expressing the soluble form of VEGF receptor-2 (sVEGFR2) driven by a hypoxia-responsive element (HRE)-regulated… CONTINUE READING
15 Citations
56 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 56 references

Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo

  • QayumN, ImJ, StratfordMR, BernhardEJ, McKennaWG, RJ Muschel
  • Clin Cancer Res
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…